We at Cellogen Therapeutics use advanced cellular engineering methods and gene therapy-based approaches to find curative treatment for various hematological malignancies, solid tumors and hemoglobinopathies.
We have conceptualised and designed state-of-the-arts third and fourth generation CAR constructs (CAR T-cell therapies) for Blood cancers such as leukaemia, lymphoma. We have also developed genetic therapies for Beta-Thalassemia and sickle cell disease, the two most common debilitating blood disorders.
Over the last decade, the impressive clinical outcome of cell and gene-based therapies has given a new hope for patients suffering from life-threatening diseases. Cellular and gene therapies have transformed the therapeutic landscape by providing long-lasting and permanent cure. However, these therapeutic modalities are currently expensive and limited to a few countries. Our vision is to make these revolutionary therapies available to masses, particularly for the patients in India where the majority of the patients cannot afford the cost. We will provide a convenient and cost-effective solution by indigenously manufacturing these therapeutic modalities.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Plot No-6, Mahnus Tower, Sector 73, Noida, Noida,uttar Pradesh 201301,india
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://cellogentherapeutics.com
- Keywords
- Bengaluru.
- HQ
- Noida, Uttar Pradesh
Cellogen Therapeutics Questions
Cellogen Therapeutics's website is http://cellogentherapeutics.com
Cellogen Therapeutics's LinkedIn profile is https://in.linkedin.com/company/cellogen-therapeutics
Cellogen Therapeutics has
13 employees.
View email and phone details for 13
employees at Cellogen Therapeutics.
Cellogen Therapeutics's industry is
Biotechnology Research
Cellogen Therapeutics's top competitors are
Immuneel Therapeutics Pvt. Ltd.,
Rapture Biotech Bengaluru,
Csir-Igib,
Jonlnbio,
Dr. Reddy's Laboratories,
Immunoact,
Strand Life Sciences,
Nkure Therapeutics,
Sangene Biotech,
Cordon Genomics.
Cellogen Therapeutics's categories are Biotechnology Research
Cellogen Therapeutics's founding year is 2021
